Rybelsus approval date fda?

When did the FDA approve Rybelsus (semaglutide) for use?

The FDA approved Rybelsus (oral semaglutide) on September 21, 2019 for adults with type 2 diabetes to improve glycemic control [1].

Did the FDA approve any later expansions or label updates?

After the initial approval in 2019, the label has been updated as additional clinical evidence became available and for other regulatory reasons. Exact “approval dates” for later label indications depend on the specific supplement/action by the FDA, not just the original approval date [1].

Where can I verify the approval date in an FDA listing?

You can confirm the original approval date through FDA drug-approval records and summaries, and cross-check it with industry patent/market tracking sources such as DrugPatentWatch [1][2].

Sources

[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213051
[2] https://drugpatentwatch.com/